Synergistic action of protein kinase Cθ and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells

European Journal of Immunology

Volumn 29, Issue 11, 1999, Pages 3549-3561

  Villunger, Andreas ^a,c   Ghaffari Tabrizi, Nassim ^a   Tinhofer, Inge ^a   Krumböck, Nina ^a   Bauer, Birgit ^a   Schneider, Thomas ^a   Kasibhatla, Shailaja ^b   Greil, Richard ^a   Baier Bitterlich, Gabriele ^a   Überall, Florian ^a   Green, Douglas R ^b   Baier, Gottfried ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

AP 1; Calcineurin; Fas ligand; MEKK; Protein kinase C ; Rac

Indexed keywords

4 HYDROXYTAMOXIFEN; CALCINEURIN; ESTROGEN RECEPTOR; FAS LIGAND; LUCIFERASE; MUTANT PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FUSION GENE; GENE INDUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; T LYMPHOCYTE;

EID: 0032703372     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199911)29:11<3549::AID-IMMU3549>3.0.CO;2-Q     Document Type: Article

References (38)

1. Lynch, D. H., Ramsdell, F. and Alderson, M. R., Fas and FasL in the homeostatic regulation of immune responses [see comments]. Immunol. Today 1995. 16: 569-574.
2. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
3. Rothstein, T. L., Wang, J. K., Panka, D. J., Foot, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T. and Marshak-Rothstein, A., Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995. 374: 163-165.
4. Rensing-Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P., Krammer, P. H. and Fontana, A., Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 1995. 25: 2253-2258.
5. Griffith, T. S. and Ferguson, T. A., The role of FasL-induced apoptosis in immune privilege [published erratum appears in Immunol. Today 1997 18(7): 361]. Immunol. Today 1997. 18: 240-244.
6. Stuart, P. M., Griffith, T. S., Usui, N., Repose, J., Yu, X. and Ferguson, T. A., CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 1997. 99: 396-402.
7. Sonoda, Y. and Streilein, J. W., Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992. 54: 694-704.
8. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagata, S., Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995. 154: 3806-3813.
9. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A. and Duke, R. C., A role for CD95 ligand in preventing graft rejection [see comments] [published erratum appears in Nature 1998. 394(6689): 133]. Nature 1995. 377: 630-632.
10. Lau, H. T., Yu, M., Fontana, A. and Stoeckert, C. J., Jr., Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice [see comments]. Science 1996. 273: 109-112.
11. Vignaux, F., Vivier, E., Malissen, B., Depraetere, V., Nagata, S. and Golstein, P., TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 1995. 181: 781-786.
12. Osborne, B. A., Apoptosis and the maintenance of homeostasis in the immune system. Curr. Opin. Immunol. 1996. 8: 245-254.
13. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors. Cell 1994. 76: 263-274.
14. Latinis, K. M., Carr, L. L., Peterson, E. J., Norian, L. A., Eliason, S L. and Koretzky, G. A., Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 1997. 158: 4602-4611.
15. Latinis, K. M., Norian, L. A., Eliason, S. L. and Koretzky, G. A., Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1997. 272: 31427-1434.
16. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273: 4416-4423.
17. Baier-Bitterlich, G., Uberall, F., Bauer, B., Fresser, F., Wachter, H., Grunicke, H., Utermann, G., Altman, A. and Baier, G., Protein kinase C-theta isoenzyme selective Stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell. Biol. 1996. 16: 1842-1850.
18. Brunner, T., Mogil, R. J., LaFace, D. et al., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]. Nature 1995. 373: 441-444.
19. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) [see comments]. Nature 1995. 373: 438-441.
20. Faris, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D. R., Koretzky, G. A. and Nel, A., The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 1998. 160: 134-144.
21. Faris, M., Latinis, K. M., Kempiak, S. J., Koretzky, G. A. and Nel, A., Stress-induced Fas ligand expression in T cells in mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. mol. Cell. Biol. 1998. 18: 5414-5424.
22. Isakov, N., McMahon, P. and Altman, A., Selective post-transcriptional down-regulation of protein kinase C isoenzymes in leukemic T cells chronically treated with phorbol ester. J. Biol. Chem. 1990. 265: 2091-2097.
23. Baier, G., Telford, D., Giampa, L., Coggeshall, K. M., Baier-Bitterlich, G., Isakov, N. and Altman, A., Molecular cloning and characterization of PKC θ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells J. Biol. Chem. 1993. 268: 4997-5004.
24. Monks, C. R., Kupfer, H., Tamir, I., Barlow, A. and Kupfer, A., Selective modulation of protein kinase C-theta during T-cell activation. Nature 1997. 385: 83-86.
25. Werlen, G., Jacinto, E., Xia, Y. and Karin, M., Calcineurin-preferentially synergizes with PKC-theta to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 1998. 17: 3101-3111.
26. Ghaffari-Tabrizi, N., Bauer, B., Villunger, A., Baier-Bitterlich, G., Altman, A., Utermann, G., Uberall, F. and Baier, G., Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 1999. 29: 132-142.
27. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marme, D. and Schachtele, C., Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 1993. 268: 9194-9197.
28. Qatsha, K. A., Rudolph, C., Marme, D., Schachtele, C. and May, W. S., Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low- level-producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA 1993. 90: 4674-4678.
29. Uberall, F., Giselbrecht, S., Hellbert, K., Fresser, F., Bauer, B., Gschwendt, M., Grunicke, H. H. and Baier, G., Conventional PKC-alpha, novel PKC-epsilon and PKC-theta, but not atypical PKC-lambda are MARCKS kinases in intact NIH 3T3 fibroblasts. J. Biol. Chem. 1997. 272: 4072-4078.
30. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A. and Green, D. R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol. Cell 1998. 1: 543-551.
31. Kampfer, S., Hellbert, K., Villunger, A., Doppler, W., Baler, G., Grunicke, H. H. and Uberall, F., Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta. EMBO J. 1998. 17: 4046-4055.
32. O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J. and O'Neill, E. A., FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992. 357: 692-694.
33. Lee, F. S., Hagler, J., Chen, Z. J. and Maniatis, T., Activation of the IאBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997. 88: 213-222.
34. Kerkhoff, E. and Rapp, U. R., Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 1997. 17: 2576-2586.
35. Serfling, E., Avots, A. and Neumann, M., The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochem. Biophys. Acta 1995. 1263: 181-200.
36. Datta, R., Kojima, H., Yoshida, K. and Kufe, D., Caspase-3-mediated cleavage of protein kinase C6 in induction of apoptosis. J. Biol. Chem. 1997. 272: 20317-20320.
37. Smith, D. J., McGuire, M. J., Tocci, M. J. and Thiele, D. L., IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J Immunol. 1997. 158: 163-170.
38. Bossi, G. and Griffiths, G. M., Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 1999. 5: 90-96.